Friday, December 26, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Glivec Receives US Approval As First Treatment To Reduce Risk Of Cancer Returning In Patients With Gastrointestinal Stromal Tumors
http://www.medicalnewstoday.com/articles/133953.php
Novartis announced that Glivec® (imatinib) has been approved by the US Food and Drug Administration (FDA) for the post-surgery treatment of adult patients following complete surgical removal of Kit (CD117)-positive gastrointestinal stromal tumors (GIST).

Newly Identified Gene Powerful Predictor Of Colon Cancer Metastasis - Low Gene Activity - Higher Survival Rate
http://www.medicalnewstoday.com/articles/133796.php
Cancer Researchers at the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch and the Charite - Universitats Medizin Berlin (Germany) have identified a gene which enables them to predict for the first time with high probability if colon cancer is going to metastasize.

Prophylactic Antibiotics, Air Quality Control And Barrier Isolation Combined Reduce Mortality In High-Risk Cancer Patients Receiving Chemotherapy
http://www.medicalnewstoday.com/articles/133794.php
A combination of prophylactic antibiotics, barrier isolation and air quality control measures substantially reduces the risk of death in high-risk cancer patients who are immunocompromised due to chemotherapy or stem cell transplantation.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Newly Identified Gene Powerful Predictor Of Colon Cancer Metastasis - Low Gene Activity - Higher Survival Rate
http://www.medicalnewstoday.com/articles/133796.php
Cancer Researchers at the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch and the Charite - Universitats Medizin Berlin (Germany) have identified a gene which enables them to predict for the first time with high probability if colon cancer is going to metastasize.

----------------------------------------------
** LUNG CANCER News **

PharmaMar Announces The Initiation Of Phase II Studies With Irvalec®
http://www.medicalnewstoday.com/articles/133805.php
PharmaMar, a biotechnology company from Zeltia Group, announces the initiation of a Phase II multicenter study of Irvalec® in patients with non- microcitic lung cancer. The study will test the therapy in patients who have undergone platinum based chemotherapy.

Merck Serono Acquires Manufacturing Rights And Facility For Stimuvax From Oncothyreon
http://www.medicalnewstoday.com/articles/133798.php
Merck Serono, a division of Merck KGaA, announced recently that it has modified the license from Oncothyreon to include the right to manufacture Stimuvax® (BLP25 liposome vaccine) and also has purchased current inventory and certain assets used for the manufacture of Stimuvax from Oncothyreon Inc.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Change Determinants In PSA Over Time - Its Association With Recurrence After External Beam Radiation Therapy For Prostate Cancer In 5 Large Cohorts
http://www.medicalnewstoday.com/articles/133737.php
UroToday.com - In the November 1, 2008 issue of <i>International Journal of Radiation Oncology, Biology, Physics</i>, Dr. Cécile Proust-Lima and colleagues presented a linear mixed model to construct patient PSA profiles after radiotherapy (XRT) for prostate cancer (CaP).

Oncologic Outcome After Laparoscopic Radical Prostatectomy: 10 Years Of Experience
http://www.medicalnewstoday.com/articles/133734.php
UroToday.com - Long-term oncologic outcomes for laparoscopic radical prostatectomy (LRP) are lacking. In the online edition of <i>European Urology</i>, Dr. Karim Touijer and associates from Dr.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

No comments: